Patients with cancer at the margins of reproductive age had reduced levels of anti‐Müllerian hormone compared with patients experiencing infertility (original ) (raw )Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies
Frank Jong
Human Reproduction, 2008
View PDFchevron_right
Anti-Mullerian Hormone and Antral Follicle Count Reveal a Late Impairment of Ovarian Reserve in Patients Undergoing Low-Gonadotoxic Regimens for Hematological Malignancies
Alessio Perandini
The Oncologist, 2013
View PDFchevron_right
Anti-Müllerian Hormone and Antral Follicle Count Reveal a Late Impair- Ment of Ovarian Reserve in Patients Undergone Low Gonadotoxic Regimens for Haematological Malignancies
Alessio Perandini
2013
View PDFchevron_right
The effect of cancer treatment on female fertility and strategies for preserving fertility
Theodoros Maltaris , Heinz Koelbl
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2007
View PDFchevron_right
Endocrine function and fertility preservation in women surviving cancer : a study on cancer treatment and fertility
Matthys Botha
View PDFchevron_right
Anti-Müllerian Hormone as a Sensitive Marker of Ovarian Function in Young Cancer Survivors
Beata Zelazowska-rutkowska
International Journal of Endocrinology, 2013
View PDFchevron_right
Reproduction post-chemotherapy in young cancer patients
D. Meirow
Molecular and Cellular Endocrinology, 2000
View PDFchevron_right
Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation
ariel revel
BMC Women's Health, 2021
View PDFchevron_right
Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results
Cécile Gallo , C. Lefebvre , C. Decanter
Reproductive BioMedicine Online, 2010
View PDFchevron_right
OPTIONS TO PRESERVE FERTILITY BEFORE ONCOLOGICAL TREATMENT: CRYOPRESERVATION OF OVARIAN TISSUE AND ITS CLINICAL APPLICATION
P. Simon , Yvon Englert
Acta Clinica Belgica, 2006
View PDFchevron_right
Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy
Yasmin Gosiengfiao , Maureen Prewitt
Fertility and Sterility, 2013
View PDFchevron_right
Fertility Preservation in Female Cancer Patients: A Review
Pablo Sanhueza
Journal of Safog With Dvd, 2009
View PDFchevron_right
How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries
Zeev Blumenfeld
The Oncologist, 2007
View PDFchevron_right
Impact of cancer therapies on ovarian reserve
Maureen Prewitt
Fertility and Sterility, 2012
View PDFchevron_right
Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation
Joseph Lessing
Fertility and Sterility, 2012
View PDFchevron_right
Fertility preservation strategies in women undergoing chemotherapy for haematological malignancy
Igor Crha , Martin Huser , Pavel Ventruba
European Clinics in Obstetrics and Gynaecology, 2006
View PDFchevron_right
Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer
Mikkel Rosendahl , Tom Kelsey
View PDFchevron_right
Fertility preservation in women with malignant tumors and gonadotoxic treatments
Michael Von Wolff
Deutsches Ärzteblatt international, 2012
View PDFchevron_right
Anti-Müllerian hormone screening to assess ovarian reserve among female survivors of childhood cancer
SAMEERA AHMED
Journal of Cancer Survivorship, 2014
View PDFchevron_right
Impact of first-line cancer treatment on the follicle quality in cryopreserved ovarian samples from girls and young women
Marcus Sjödin
Human Reproduction, 2019
View PDFchevron_right
Longitudinal observation of serum anti-Müllerian hormone in three girls after cancer treatment
Makiko Tachibana
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2016
View PDFchevron_right
A Warning Call for Fertility Preservation Methods for Women Undergoing Gonadotoxic Cancer Treatment
Andreea Carp-Veliscu
Medicina, 2021
View PDFchevron_right
Fertility preservation in women with cancer: update and perspectives
Fernanda Parreiras
Revista Médica de Minas Gerais, 2013
View PDFchevron_right
Fertility Preservation in Female Cancer Patients
Simona Vailati , Eleonora Matteucci , Massimo Moscarini , F. Peccatori
Fertility and Sterility, 2005
View PDFchevron_right
Timing of fertility preservation procedures in a cohort of female patients with cancer
Leoni Louwé
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2012
View PDFchevron_right
The Late Effects of Cancer Treatment on Female Fertility and the Current Status of Fertility Preservation—A Narrative Review
Hanna Nilsson
Life
View PDFchevron_right
Infertility in reproductive‐age female cancer survivors
Gwendolyn Quinn
View PDFchevron_right
Acute onset of ovarian dysfunction in young females after start of cancer treatment
Ingrid Øra
Pediatric Blood & Cancer, 2013
View PDFchevron_right
Fertility-sparing in cancer patients
Milan Terzic
Clinical and Experimental Obstetrics & Gynecology
View PDFchevron_right
Methods for preserving fertility in young women suffering from cancer: some aspects of ovarian tissue cryopreservation
M. Sedlackova
Bratislava Medical Journal, 2012
View PDFchevron_right
Combination of fertility preservation strategies in young women with recently diagnosed cancer
Petr Janku , Igor Crha , Martin Huser
European journal of gynaecological oncology
View PDFchevron_right
Assessing The Impact Of Cancer Therapies On Ovarian Reserve
jill ginsberg
Fertility and Sterility
View PDFchevron_right